Stewards, Inc. (SWRD) · Nov 3, 2026 · New debt

Stewards convertible financing funds PIXL, adds dilution risk

$5.5M convertible note — $5.5M purchase price for $6.05M principal; conversion at 90% of lowest 5-day VWAP

Stewards secured convertible financing to pursue the 330-unit PIXL acquisition, but the 90%-of-VWAP conversion feature and equity sweep make the capital costly.

Stewards is trying to build a two-part platform: private-credit lending alongside income-producing real estate. The immediate backdrop is liquidity pressure—a June 30, 2026 filing disclosed negative working capital, a $12.9 million first-half net loss, $10.1 million of operating cash burn, and dependence on additional financing—while PIXL is the next 330-unit multifamily asset in the real-estate expansion.

The financing does move the PIXL plan from intention toward funding, but not toward a completed acquisition. Stewards received $5.5 million of gross purchase price and says net proceeds of approximately $4.937 million will fund PIXL and general corporate purposes, yet it explicitly has no definitive PIXL purchase agreement and warns the acquisition may not close on the expected terms or at all.

The capital is unusually shareholder-unfriendly even before any conversion. The note carries a 10% original issue discount, a guaranteed 10% interest charge, and a floating conversion price set at 90% of the lowest daily VWAP over the prior five trading days. That structure makes the repayment burden and eventual share issuance rise as the stock price weakens. 〔0〕

The note also constrains Stewards’ ability to finance its next steps. The investor receives full-ratchet anti-dilution protection, participation and most-favored-nation rights, while Stewards must apply 50% of gross proceeds from equity or equity-linked financings to repayment. The company is therefore buying near-term liquidity at the cost of future financing flexibility and potentially substantial dilution; the 220,199 commitment shares are only the visible upfront piece. 〔1〕

The transaction is not yet a full $20 million financing. Only the initial $5.5 million tranche closed; additional tranches up to $20 million of purchase price require mutual agreement, an effective resale registration statement, shareholder approval and sufficient share capacity. The majority holders have already approved issuance beyond the 19.99% Nasdaq cap, but the placement-agent warrant shares still need supplemental approval. 〔2〕

Bottom line: This keeps the PIXL strategy alive and supplies urgently needed cash, but it does so through costly, variable-price convertible debt that weakens financing flexibility and raises dilution risk. The event is therefore mixed on the business plan, leaning negative on capital quality rather than a clean strategic advance.

What to watch next

PIXL definitive agreement; S-1 filing due November 27

Original filing on SEC EDGAR